Copyright
©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 105228
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.105228
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.105228
Figure 2 Downregulation of farnesoid X receptor expression in mesangial cells under high glucose conditions, farnesoid X receptor has a positive regulatory effect on binding immunoglobulin protein expression in mesangial cells.
A: Bar chart shows that the message RNA level of farnesoid X receptor (FXR) decreases with increasing glucose concentration, as detected by quantitative real-time polymerase chain reaction; B: Western blot shows that the protein level of FXR decreases with increasing glucose concentration; C: Immunocytochemical staining detected a decrease in FXR expression in high glucose-treated mesangial cells compared to the control group; D: Western blot detection shows a synchronous decrease in binding immunoglobulin protein (BiP) expression after small interfering RNA inhibition of FXR; E: Western blot detection of the effect of different concentrations of FXR agonists or inhibitors on BiP protein levels in mesangial cells. bP < 0.01. cP < 0.001. HG: High glucose; INT-747: Obeticholic acid; FXR: Farnesoid X receptor; NC: Negative control; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; DAB: 3,3’-diaminobenzidine color development; BiP: Binding immunoglobulin protein; TUBLIN: Tubulin antibody.
- Citation: Tang JY, Chong YJ, Yang L, Li X, Yang Y, Li JC, Mu J. Activation of farnesoid X receptor upregulates binding immunoglobulin protein expression and alleviates diabetic nephropathy. World J Diabetes 2025; 16(8): 105228
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/105228.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.105228